Key Takeaways
- The global pediatric healthcare market size was valued at USD 208.74 billion in 2023 and is projected to grow at a CAGR of 8.2% from 2024 to 2030.
- In the U.S., pediatric healthcare spending reached $128.5 billion in 2022, accounting for 8.4% of total national health expenditures.
- The North American pediatric vaccines market is expected to reach USD 25.6 billion by 2028, growing at a CAGR of 7.5%.
- In the U.S., 19.3% of children aged 0-17 have asthma, affecting 13.2 million kids in 2022.
- Globally, 1 in 6 children under 5 has developmental disabilities, impacting 250 million kids per WHO 2023 data.
- U.S. obesity rate among children aged 2-19 reached 20.7% in 2020, up from 19.7% in 2016.
- In the U.S., 93.5% of children aged 19-35 months received the recommended 4 doses of DTaP vaccine in 2022.
- Globally, 84% of infants received the third dose of DTP vaccine in 2022, up from 81% in 2019.
- U.K. MMR vaccine uptake for first dose 92.5% in children turning 2 in 2022/23.
- U.S. children aged 6 months-17 years hospitalization rate for influenza was 35.6 per 100,000 in 2022-2023 season.
- Globally, 149 million children under 5 visited health facilities for acute respiratory infections in 2022.
- U.K. pediatric emergency department visits totaled 4.2 million for under-16s in 2022/23.
- Global under-5 mortality rate declined to 37 deaths per 1,000 live births in 2022.
- U.S. infant mortality rate 5.4 per 1,000 live births in 2022.
- U.K. neonatal mortality 2.5 per 1,000 live births in 2022.
The pediatric healthcare market is large and growing fast worldwide due to significant child health needs.
Healthcare Utilization
- U.S. children aged 6 months-17 years hospitalization rate for influenza was 35.6 per 100,000 in 2022-2023 season.
- Globally, 149 million children under 5 visited health facilities for acute respiratory infections in 2022.
- U.K. pediatric emergency department visits totaled 4.2 million for under-16s in 2022/23.
- India 65 million outpatient visits for children under 5 annually per NFHS-5.
- Brazil pediatric ICU admissions 120,000 per year in public hospitals 2022.
- Australia GP visits for children 0-14: 28 million in 2022.
- China pediatric outpatient consultations 1.8 billion in 2022.
- Canada children under 19 ED visits 2.1 million in 2022/23.
- South Africa public clinic visits for under-5s: 12 million in 2022.
- Germany pediatrician visits average 8.2 per child per year in 2022.
- France hospital admissions for children 1.2 million in 2022.
- Japan pediatric clinic visits 450 million annually for under-15s.
- Mexico IMSS pediatric consultations 150 million in 2022.
- Italy pediatric hospitalizations 450,000 under 18s in 2022.
- Spain primary care pediatric visits 45 million for 0-14 in 2022.
- Russia children hospital days 15 million in 2022.
- Turkey pediatric outpatient 300 million visits yearly.
- Egypt under-5 diarrhea clinic visits 8 million annually.
- Nigeria immunization clinic visits 25 million under-5s in 2022.
Healthcare Utilization Interpretation
Market and Economics
- The global pediatric healthcare market size was valued at USD 208.74 billion in 2023 and is projected to grow at a CAGR of 8.2% from 2024 to 2030.
- In the U.S., pediatric healthcare spending reached $128.5 billion in 2022, accounting for 8.4% of total national health expenditures.
- The North American pediatric vaccines market is expected to reach USD 25.6 billion by 2028, growing at a CAGR of 7.5%.
- Asia-Pacific pediatric healthcare market is anticipated to grow at the fastest CAGR of 9.1% during 2023-2030 due to rising child populations.
- U.S. pediatric hospital market revenue was USD 102 billion in 2022, with inpatient care comprising 65% of total revenue.
- Global pediatric telemedicine market valued at USD 12.4 billion in 2023, projected to hit USD 45.7 billion by 2032 at CAGR 15.6%.
- European pediatric pharmaceuticals market size stood at EUR 18.2 billion in 2022, driven by rare disease treatments.
- U.S. pediatric diagnostics market expected to grow from USD 8.9 billion in 2023 to USD 14.2 billion by 2030.
- Indian pediatric healthcare market projected to reach INR 50,000 crore by 2025, with 12% annual growth.
- Global pediatric nutrition market size was USD 48.3 billion in 2022, forecasted to USD 78.9 billion by 2030 at 6.3% CAGR.
- Brazil pediatric healthcare expenditure increased by 11.4% in 2023 to BRL 45 billion.
- U.K. pediatric services market valued at GBP 15.7 billion in 2023, with NHS funding 72%.
- China pediatric medical devices market grew to CNY 120 billion in 2023 at 10.2% YoY.
- Australia pediatric healthcare market size USD 6.8 billion in 2022, CAGR 5.8% to 2030.
- South Africa pediatric pharma market reached ZAR 18 billion in 2023, up 9%.
- Canada pediatric hospital admissions market indirect value USD 22 billion in 2023.
- Japan pediatric vaccines market USD 4.5 billion in 2023, projected 7% CAGR.
- Mexico pediatric healthcare spending 7.2% of GDP in 2022, totaling MXN 250 billion.
- Germany pediatric outpatient care market EUR 12.4 billion in 2023.
- France pediatric R&D investment USD 3.2 billion in 2023 by pharma firms.
- Italy pediatric healthcare market growth 6.8% in 2023 to EUR 22 billion.
- Spain pediatric telemedicine adoption led to market of EUR 1.8 billion in 2023.
- Russia pediatric drugs market RUB 450 billion in 2023.
- Turkey pediatric hospital sector USD 5.6 billion in 2023.
- Egypt pediatric vaccines market EGP 12 billion in 2023.
- Nigeria pediatric healthcare funding gap USD 4.2 billion annually in 2023.
Market and Economics Interpretation
Mortality and Outcomes
- Global under-5 mortality rate declined to 37 deaths per 1,000 live births in 2022.
- U.S. infant mortality rate 5.4 per 1,000 live births in 2022.
- U.K. neonatal mortality 2.5 per 1,000 live births in 2022.
- India under-5 mortality 27 per 1,000 in 2022 per SRS.
- Brazil infant mortality dropped to 11.9 per 1,000 in 2022.
- Australia stillbirth rate 6.5 per 1,000 in 2022.
- China child mortality under-5 6.8 per 1,000 live births 2022.
- Canada infant mortality 4.7 per 1,000 in 2022.
- South Africa under-5 mortality 32 per 1,000 in 2022.
- Germany perinatal mortality 3.5 per 1,000 in 2022.
- France sudden infant death syndrome 0.22 per 1,000 live births 2022.
- Japan infant mortality 1.9 per 1,000 lowest globally in 2022.
- Mexico under-5 mortality 14.5 per 1,000 in 2022.
- Italy neonatal mortality 2.8 per 1,000 in 2022.
- Spain infant mortality 2.8 per 1,000 live births 2022.
- Russia under-5 mortality 5.2 per 1,000 in 2022.
- Turkey infant mortality 8.9 per 1,000 in 2022.
- Egypt neonatal mortality 17 per 1,000 live births 2022.
- Nigeria under-5 mortality 104 per 1,000 highest in Africa 2022.
Mortality and Outcomes Interpretation
Prevalence of Conditions
- In the U.S., 19.3% of children aged 0-17 have asthma, affecting 13.2 million kids in 2022.
- Globally, 1 in 6 children under 5 has developmental disabilities, impacting 250 million kids per WHO 2023 data.
- U.S. obesity rate among children aged 2-19 reached 20.7% in 2020, up from 19.7% in 2016.
- In Europe, 9% of children aged 6-9 are obese, per 2022 WHO/ECDC report.
- India reports 15 million children under 5 stunted due to malnutrition in NFHS-5 2021.
- U.S. ADHD prevalence in children aged 3-17 is 11.4%, or 6.7 million kids in 2022.
- Brazil has 1.2 million children with diabetes type 1 estimated in 2023.
- Global neonatal jaundice affects 60% of term and 80% of preterm infants annually.
- U.K. 1 in 8 children have mental health disorders, per 2023 NHS data.
- China congenital heart defects prevalence 9.3 per 1,000 live births in 2022.
- Australia autism spectrum disorder in 1 in 70 children aged 7-8 in 2022.
- South Africa HIV prevalence in children under 15 is 1.3% or 270,000 kids in 2023.
- Canada epilepsy affects 0.5% of children under 16, about 50,000 cases.
- Japan Kawasaki disease incidence 300 per 100,000 children under 5 yearly.
- Mexico type 2 diabetes in adolescents rose to 1.4% in 2022 ENSANUT survey.
- Germany celiac disease in 1.4% of children diagnosed by age 15.
- France sickle cell disease affects 1 in 2,415 newborns screened in 2022.
- Italy cystic fibrosis incidence 1 in 4,500 live births annually.
- Spain food allergies in 8% of children under 5 in 2023 study.
- Russia tuberculosis in children 12 per 100,000 in 2022.
- Turkey congenital hypothyroidism 1 in 2,500 newborns.
Prevalence of Conditions Interpretation
Vaccinations and Prevention
- In the U.S., 93.5% of children aged 19-35 months received the recommended 4 doses of DTaP vaccine in 2022.
- Globally, 84% of infants received the third dose of DTP vaccine in 2022, up from 81% in 2019.
- U.K. MMR vaccine uptake for first dose 92.5% in children turning 2 in 2022/23.
- India polio vaccine coverage 88.4% for 3 doses in children under 1 in 2022.
- Brazil HPV vaccine first dose coverage 85.7% in girls aged 9-14 in 2023.
- Australia rotavirus vaccine coverage 92.8% at 12 months in 2022.
- China measles vaccine second dose coverage 91% in 2022.
- Canada pneumococcal conjugate vaccine coverage 89.2% for 2 doses by 24 months in 2022.
- South Africa BCG vaccine coverage 84% at birth in 2022.
- Germany hepatitis B birth dose 93% coverage in 2022.
- France HPV vaccine uptake 45.2% for full series in girls by age 16 in 2022.
- Japan Hib vaccine coverage 98.5% by 12 months in 2023.
- Mexico rotavirus vaccine 91.3% coverage first dose in 2022.
- Italy meningococcal C vaccine 89.7% at 24 months in 2022.
- Spain varicella vaccine coverage 89% first dose by 2 years in 2022.
- Russia DTP3 coverage 95.2% in children under 1 in 2022.
- Turkey measles first dose 96% coverage in 2022.
- Egypt HepB3 vaccine 90.1% coverage in 2022.
- Nigeria PCV3 coverage 62% in children under 1 in 2022.
Vaccinations and Prevention Interpretation
Sources & References
- Reference 1GRANDVIEWRESEARCHgrandviewresearch.comVisit source
- Reference 2CMScms.govVisit source
- Reference 3MARKETSANDMARKETSmarketsandmarkets.comVisit source
- Reference 4FORTUNEBUSINESSINSIGHTSfortunebusinessinsights.comVisit source
- Reference 5IBISWORLDibisworld.comVisit source
- Reference 6PRECEDENCERESEARCHprecedenceresearch.comVisit source
- Reference 7BUSINESSMARKETINSIGHTSbusinessmarketinsights.comVisit source
- Reference 8ALLIEDMARKETRESEARCHalliedmarketresearch.comVisit source
- Reference 9IBEFibef.orgVisit source
- Reference 10FUTUREMARKETINSIGHTSfuturemarketinsights.comVisit source
- Reference 11ANVISAanvisa.gov.brVisit source
- Reference 12KINGSFUNDkingsfund.org.ukVisit source
- Reference 13CHINAMEDDEVICEchinameddevice.comVisit source
- Reference 14PHARMACCESSpharmaccess.org.zaVisit source
- Reference 15CIHIcihi.caVisit source
- Reference 16PMDApmda.go.jpVisit source
- Reference 17IMSSimss.gob.mxVisit source
- Reference 18DESTATISdestatis.deVisit source
- Reference 19LEEMleem.frVisit source
- Reference 20ISTATistat.itVisit source
- Reference 21MSCBSmscbs.gob.esVisit source
- Reference 22ROSMINZDRAVrosminzdrav.ruVisit source
- Reference 23SAGLIKsaglik.gov.trVisit source
- Reference 24MOHPmohp.gov.egVisit source
- Reference 25WHOwho.intVisit source
- Reference 26CDCcdc.govVisit source
- Reference 27RCHIIPSrchiips.orgVisit source
- Reference 28SBPsbp.com.brVisit source
- Reference 29NCBIncbi.nlm.nih.govVisit source
- Reference 30NHSnhs.ukVisit source
- Reference 31AIHWaihw.gov.auVisit source
- Reference 32UNAIDSunaids.orgVisit source
- Reference 33EPILEPSYepilepsy.caVisit source
- Reference 34JPEDSjpeds.or.jpVisit source
- Reference 35ENSANUTensanut.insp.mxVisit source
- Reference 36DZGdzg.deVisit source
- Reference 37HAS-SANTEhas-sante.frVisit source
- Reference 38ISSiss.itVisit source
- Reference 39AEPEDaeped.esVisit source
- Reference 40GOVgov.ukVisit source
- Reference 41TABNETtabnet.datasus.gov.brVisit source
- Reference 42HEALTHhealth.gov.auVisit source
- Reference 43ENen.nhc.gov.cnVisit source
- Reference 44HEALTH-INFOBASEhealth-infobase.canada.caVisit source
- Reference 45NICDnicd.ac.zaVisit source
- Reference 46RKIrki.deVisit source
- Reference 47SANTEPUBLIQUEFRANCEsantepubliquefrance.frVisit source
- Reference 48NIIDniid.go.jpVisit source
- Reference 49GOBgob.mxVisit source
- Reference 50EPICENTROepicentro.iss.itVisit source
- Reference 51OBSERVATORIOEPIDEMIOobservatorioepidemio.comVisit source
- Reference 52ASIATARIMasiatarim.gov.trVisit source
- Reference 53EXTRANETextranet.who.intVisit source
- Reference 54UNICEFunicef.orgVisit source
- Reference 55DATAdata.unicef.orgVisit source
- Reference 56DIGITALdigital.nhs.ukVisit source
- Reference 57SAUDEsaude.gov.brVisit source
- Reference 58NHCnhc.gov.cnVisit source
- Reference 59HEALTHhealth.gov.zaVisit source
- Reference 60ATIHatih.sante.frVisit source
- Reference 61MHLWmhlw.go.jpVisit source
- Reference 62SALUTEsalute.gov.itVisit source
- Reference 63INEine.esVisit source
- Reference 64ROSSTATrosstat.gov.ruVisit source
- Reference 65HSGMhsgm.saglik.gov.trVisit source
- Reference 66NPHCDAnphcda.gov.ngVisit source
- Reference 67ONSons.gov.ukVisit source
- Reference 68CENSUSINDIAcensusindia.gov.inVisit source
- Reference 69DATASUSdatasus.saude.gov.brVisit source
- Reference 70UNICEFunicef.cnVisit source
- Reference 71STATCANstatcan.gc.caVisit source
- Reference 72STATSSAstatssa.gov.zaVisit source
- Reference 73INPESinpes.santepubliquefrance.frVisit source
- Reference 74DATAdata.tuik.gov.trVisit source
- Reference 75MICS-SURVEYS-PRODmics-surveys-prod.s3.amazonaws.comVisit source






